z-logo
open-access-imgOpen Access
Increased Serum Copper in Pulmonary Hypertension: Involvement of Thromboxane?
Author(s) -
Joshua Backon
Publication year - 1986
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000194911
Subject(s) - medicine , pulmonary hypertension , thromboxane , thromboxane a synthase , thromboxane a2 , cardiology , platelet
Dr. Joshua Backon, Brookman Clinic, POB 16336, Jerusalem (Israel) Dear Sir: References Ahmed and Sackner [1985] have recently reported increased serum copper in primary pulmonary hypertension and suggested involvement of the α-adrenergic system, especially as dopamine/1⁄8ydrox-ylase, is copper dependent. I would like to suggest that thromboxane could be involved and is regulated by copper levels. Thromboxane is involved in pulmonary hypertension [Frolich et al., 1980]. The distribution of copper is unbalanced in the brain and is more concentrated in the left hemisphere [Delva, 1970]. Since copper acts as a coenzyme of dopamine-ß-hy-droxylase, which converts dopamine into noradrenaline, there is a higher level of noradrenaline in the left hemisphere [Mys-lobodsky and Weiner, 1978; Oke et al., 1978]. In the pineal, neural stimulation causes the release of noradrenaline which elevates pineal-N-acetyltransferase which controls melatonin production [Namboodiri et al., 1981] and this formation of melatonin is markedly stimulated by noradrenaline [Brownstein and Axelrod, 1974]. Since melatonin is necessary for the thromboxane (TXA2) receptor to be in the active state, increased melatonin can raise TXA2 levels [Horrobin et al., 1980]. Thus, the two concepts of increased serum copper and increased thromboxane can be linked via effects on melatonin production. Ahmed, T.; Sackner, M.A.: Increased serum copper in primary pulmonary hypertension: a possible pathogenic link? Respiration 47: 243-246 (1985). Brownstein, M.; Axelrod, J.: Pineal gland: 24-hour rhythm in norepinephrine turnover. Science 184: 163-165(1974). Delva, V.A.: in Petelin, Extrapyramidal hyperkine-sis. (Medizine, Moscow 1970). Frolich, J.C.; Ogletree, M.; Peskar, B.A.; Brigham, K.L.: Pulmonary hypertension correlated to pulmonary thromboxane synthesis; in Samuelsson, Ramwell, Paoletti, Advances in prostaglandin and thromboxane research, vol. 7 (Raven Press, New York 1980). Horrobin, D.F.; Manku, M.S.; Oka, M.; et al.: Selective control of formation of 1 and 2 series pros-taglandins: a new concept in the regulation of inflammation and immunity. Future Trends in Inflammation, Royal College of Surgeons, London 1980 (MTP Press, Lancaster). Myslobodsky, M.; Weiner, M.: Clinical psychology in the chemical environment. Psychol. Rep. 43: suppl., pp. 247-276 (1978). Namboodiri, M.A.; Favilla, J.; Klein, D.C: Pineal N-acetyltransferase is inactivated by disulphide-containing peptides: insulin is the most potent. Science 213: 571-573(1981).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom